Search research articles
Contact Us
Filters
Showing results (211-220 of 229) with videos related to
Page
of 23
Sort By:
The Journal of Urology
|
March 1, 1988
Interactions between bladder tumor cells as tumor spheroids from the cell line J82 and human endothelial cells in vitro
R Knüchel, J Feichtinger, A Recktenwald, et al.
Studies in Health Technology and Informatics
|
December 9, 1995
Using human factor analysis and VR simulation techniques for the optimization of the surgical worksystem
K Radermacher, K C von Pichler, S Erbse, et al.
Nuklearmedizin. Nuclear Medicine
|
June 1, 1993
[Detection of bone involvement in malignant diseases by immunoscintigraphy of the bone marrow]
S N Reske, J H Karstens, M M Henrich, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 20, 1998
FDG PET for detection and therapy control of metastatic germ cell tumor
U Cremerius, P J Effert, G Adam, et al.
Journal of Endourology
|
January 24, 1998
Development of a biodegradable ureteric stent: surface modification and in vitro assessment
A Brauers, H Thissen, O Pfannschmidt, et al.
The Journal of Urology
|
October 1, 1991
Expression of the insulin like growth factor-binding protein 3 (IGFBP-3) gene is increased in human renal carcinomas
R L Hintz, S Bock, A V Thorsson, et al.
European Radiology
|
February 24, 2001
Diuretic-enhanced gadolinium excretory MR urography: comparison of conventional gradient-echo sequences and echo-planar imaging
C C Nolte-Ernsting, J Tacke, G B Adam, et al.
Urologia Internationalis
|
January 1, 1987
Multicellular bladder tumor spheroids in coculture with human endothelial cell monolayers
R Knüchel, F Hofstädter, J Feichtinger, et al.
Cancer Research
|
November 3, 2001
Prognostic impacts of cytogenetic findings in clear cell renal cell carcinoma: gain of 5q31-qter predicts a distinct clinical phenotype with favorable prognosis
B Gunawan, W Huber, M Holtrup, et al.
European Urology
|
August 31, 2001
Intravesical BCG in patients with carcinoma in situ of the urinary bladder: long-term results of EORTC GU Group phase II protocol 30861
G Jakse, R Hall, A Bono, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 229) with videos related to
Sort By:
Page
of 23
The Journal of Urology
|
March 1, 1988
Interactions between bladder tumor cells as tumor spheroids from the cell line J82 and human endothelial cells in vitro
R Knüchel, J Feichtinger, A Recktenwald, et al.
Studies in Health Technology and Informatics
|
December 9, 1995
Using human factor analysis and VR simulation techniques for the optimization of the surgical worksystem
K Radermacher, K C von Pichler, S Erbse, et al.
Nuklearmedizin. Nuclear Medicine
|
June 1, 1993
[Detection of bone involvement in malignant diseases by immunoscintigraphy of the bone marrow]
S N Reske, J H Karstens, M M Henrich, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 20, 1998
FDG PET for detection and therapy control of metastatic germ cell tumor
U Cremerius, P J Effert, G Adam, et al.
Journal of Endourology
|
January 24, 1998
Development of a biodegradable ureteric stent: surface modification and in vitro assessment
A Brauers, H Thissen, O Pfannschmidt, et al.
The Journal of Urology
|
October 1, 1991
Expression of the insulin like growth factor-binding protein 3 (IGFBP-3) gene is increased in human renal carcinomas
R L Hintz, S Bock, A V Thorsson, et al.
European Radiology
|
February 24, 2001
Diuretic-enhanced gadolinium excretory MR urography: comparison of conventional gradient-echo sequences and echo-planar imaging
C C Nolte-Ernsting, J Tacke, G B Adam, et al.
Urologia Internationalis
|
January 1, 1987
Multicellular bladder tumor spheroids in coculture with human endothelial cell monolayers
R Knüchel, F Hofstädter, J Feichtinger, et al.
Cancer Research
|
November 3, 2001
Prognostic impacts of cytogenetic findings in clear cell renal cell carcinoma: gain of 5q31-qter predicts a distinct clinical phenotype with favorable prognosis
B Gunawan, W Huber, M Holtrup, et al.
European Urology
|
August 31, 2001
Intravesical BCG in patients with carcinoma in situ of the urinary bladder: long-term results of EORTC GU Group phase II protocol 30861
G Jakse, R Hall, A Bono, et al.
Page
of 23